Literature DB >> 7505294

Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

D L Smith1, L B Gumery, E G Smith, D E Stableforth, M E Kaufmann, T L Pitt.   

Abstract

An epidemic of Pseudomonas cepacia occurred in an adult cystic fibrosis center in the United Kingdom, despite a policy of segregation of infected and noninfected patients within the hospital. Investigation of the outbreak by ribotyping and pulsed-field gel electrophoresis to characterize P. cepacia strain genomes together with inquiry into social contacts between patients revealed evidence of person-to-person transmission outside the hospital environment. Segregation policies aimed at reducing the spread of this infection in the cystic fibrosis community need to encompass patient contacts outside the hospital environment.

Entities:  

Mesh:

Year:  1993        PMID: 7505294      PMCID: PMC266193          DOI: 10.1128/jcm.31.11.3017-3022.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Pseudomonas cepacia--more than a harmless commensal?

Authors: 
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

2.  Pseudomonas cepacia infection in cystic fibrosis.

Authors:  D L Smith; E G Smith; L B Gumery; D E Stableforth
Journal:  Lancet       Date:  1992-01-25       Impact factor: 79.321

3.  Transmission of Pseudomonas cepacia among cystic fibrosis patients.

Authors:  L Millar-Jones; A Paull; Z Saunders; M C Goodchild
Journal:  Lancet       Date:  1992-08-22       Impact factor: 79.321

4.  Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.

Authors:  S C Aronoff; F J Quinn; R C Stern
Journal:  Pediatr Pulmonol       Date:  1991

5.  Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom.

Authors:  E J Simmonds; S P Conway; A T Ghoneim; H Ross; J M Littlewood
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

6.  Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae.

Authors:  J Garaizar; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

8.  Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.

Authors:  G Gladman; P J Connor; R F Williams; T J David
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

9.  Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis.

Authors:  M J Struelens; A Deplano; C Godard; N Maes; E Serruys
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

10.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

View more
  35 in total

1.  Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson
Journal:  Can J Infect Dis       Date:  1994-03

2.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo.

Authors:  Ronald S Flannagan; Daniel Aubert; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

5.  Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection.

Authors:  Annette C Vergunst; Annemarie H Meijer; Stephen A Renshaw; David O'Callaghan
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

6.  Pseudomonas cepacia in cystic fibrosis.

Authors:  D E Stableforth; D L Smith
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

7.  Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

Authors:  S L Butler; C J Doherty; J E Hughes; J W Nelson; J R Govan
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

Review 8.  Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation?

Authors:  A K Webb; J Egan
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

9.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.

Authors:  I Jacques; J Derelle; M Weber; M Vidailhet
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.